azomycin has been researched along with Cancer of Cervix in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (32.69) | 18.7374 |
1990's | 4 (7.69) | 18.2507 |
2000's | 21 (40.38) | 29.6817 |
2010's | 8 (15.38) | 24.3611 |
2020's | 2 (3.85) | 2.80 |
Authors | Studies |
---|---|
Bruce, J; Cairns, R; Chaudary, N; Croke, J; D'Souza, D; Dhani, N; Fyles, A; Han, K; Jaffray, D; Koritzinsky, M; Lee, TY; Metser, U; Milosevic, M; Pakbaz, S; Pintilie, M; Rouzbahman, M; Shek, T; Vines, D | 1 |
Aarnes, EK; Evensen, TS; Fjeldbo, CS; Hillestad, T; Hompland, T; Kristensen, GB; Lund, KV; Lyng, H; Nilsen, A; Salberg, UB; Skingen, VE; Stokke, T | 1 |
Andersen, LMK; Gaustad, JV; Hauge, A; Huang, R; Rofstad, EK; Simonsen, TG; Wegner, CS | 1 |
Ellingsen, C; Galappathi, K; Hompland, T; Mathiesen, B; Rofstad, EK | 1 |
Cui, P; Dai, M; Han, J; Li, H; Liu, Q; Xiu, R; Yu, M | 1 |
Moore, DH | 1 |
Bachtiary, B; Dimopoulos, J; Dudczak, R; Georg, D; Karanikas, G; Kletter, K; Kommata, S; Lukic, D; Pötter, R; Schmid, MP; Schuetz, M | 1 |
Busk, M; Horsman, MR; Jakobsen, S; Munk, OL; Overgaard, J; Skals, M; Steiniche, T; Wang, T | 1 |
Busk, M; Horsman, MR; Jakobsen, S; Mueller-Klieser, W; Overgaard, J; Steiniche, T; Walenta, S | 1 |
Ellingsen, C; Galappathi, K; Mathiesen, B; Ovrebø, KM; Rofstad, EK | 1 |
Barranger, E; Barré, E; Baruch-Hennequin, V; Delord, M; Delpech, Y; Groheux, D; Hindié, E; Homyrda, L; Schlageter, MH; Thoury, A; Tylski, P; Vercellino, L; Walker, F | 1 |
Busk, M; D'Andrea, FP; Hansen, KV; Horsman, MR; Jakobsen, S; Kallehauge, JF; Mortensen, LS; Nordsmark, M; Overgaard, J; Steiniche, T; Theil, J | 1 |
Bennewith, KL; Durand, RE; Raleigh, JA | 1 |
Airley, RE; Davidson, SE; Harris, AL; Hunter, RD; Loncaster, J; Raleigh, JA; Stratford, IJ; West, CM | 1 |
Aquino-Parsons, C; Chou, SC; Davidson, SE; Havsteen, H; Hunter, R; Ladekarl, M; Lindegaard, JC; Loncaster, J; Nordsmark, M; Overgaard, J; Raleigh, JA; Varia, M; West, C | 1 |
Azuma, Y; Chou, SC; Lininger, RA; Murphy, BJ; Raleigh, JA; Varia, MA | 1 |
Bennewith, KL; Durand, RE | 1 |
Davidson, SE; Harris, AL; Hunter, RD; Hutchison, GJ; Loncaster, JA; Price, PM; Roberts, SA; Stratford, IJ; Valentine, HR; West, CM | 1 |
Aquino-Parsons, C; Olive, P; Sobhanifar, S; Stanbridge, EJ | 1 |
Abuzallouf, S; Dayes, IS | 1 |
Aquino-Parsons, C; Banath, JP; Durand, RE; Jankovic, B; MacPhail, SH; Olive, PL; Raleigh, JA; Stanbridge, EJ | 1 |
Aquino-Parsons, C; Chou, SC; Davidson, SE; Gebski, V; Havsteen, H; Hunter, R; Lindegaard, JC; Loncaster, J; Nordsmark, M; Overgaard, J; Raleigh, JA; West, C | 1 |
Aquino-Parsons, C; Durand, RE | 1 |
Black, BE; Bush, RS; Cummings, BJ; Rauth, AM; Sorenti, VL; Thomas, GM | 1 |
Onoyama, Y | 1 |
Varghese, AJ; Whitmore, GF | 1 |
Omura, M | 1 |
Kishino, Y | 1 |
Asakawa, H; Hoshino, T; Watarai, J | 1 |
Kleine, W; Ladner, HA; Nagy, D; Stange, S | 1 |
Bennett, MH; Dische, S; Hauck, J; Minchinton, AI; Riley, PJ; Saunders, MI; Stratford, MR | 1 |
Calkins, DP; Kennedy, AS; Novotny, DB; Perez, GM; Raleigh, JA; Thrall, DE; Varia, MA | 1 |
Ballenger, CA; Calkins-Adams, DP; Fowler, WC; Novotny, DB; Raleigh, JA; Rinker, LH; Varia, MA; Weissler, MC | 1 |
Calkins-Adams, DP; Fowler, WC; Kennedy, AS; Novotny, DB; Raleigh, JA; Rinker, LH; Varia, MA | 1 |
Ballenger, CA; Calkins-Adams, DP; Chou, SC; Novotny, DB; Raleigh, JA; Varia, MA | 1 |
Begg, AC; Geboes, K; Haustermans, K; Hofland, I; Raleigh, J; Van de Pavert, L; Varia, M | 1 |
Aquino-Parsons, C; Durand, RE; Luo, C; Olive, PL; Raleigh, JA | 1 |
Bono, EL; Chou, SC; Raleigh, JA; Thrall, DE; Varia, MA | 1 |
Chou, SC; Davidson, SE; Havsteen, H; Hunter, R; Lindegaard, JC; Loncaster, J; Nordsmark, M; Overgaard, J; Raleigh, JA; Varia, M; West, C | 1 |
Aquino-Parsons, C; Lerman, MI; Liao, SY; MacPhail, SH; Olive, PL; Raleigh, JA; Stanbridge, EJ | 1 |
Balm, A; Begg, AC; Blommestijn, G; Delaere, P; Hofland, I; Janssen, H; Raleigh, JA; Sciot, R; Sprong, D; Van Velthuyzen, L; Varia, M | 1 |
Banáth, JP; Durand, RE; Olive, PL | 1 |
Fowler, JF | 1 |
Candia Carnevali, MD; de Carneri, I | 1 |
Denekamp, J; McNally, NJ | 1 |
Dische, S; Gray Errington, L; Thomlinson, RH | 1 |
abd el Baki, H; Akoush, H; Awwad, HK; el Badawy, S; el Moneim Osman, A; Fairchild, K; Zaghloul, M | 1 |
Bennett, MH; Dische, S; Orchard, R; Stratford, MR; Wardman, P | 1 |
Akçasu, A; Egehan, I; Hacibekiroğlu, M; Okkan, S; Olgun, P; Turkan, S; Uzel, R; Yazici, Z | 1 |
Bennett, MH; Des Rochers, C; Dische, S; Dunphy, EP; Minchinton, AI; Saunders, MI; Stratford, MR; Wardman, P | 1 |
2 review(s) available for azomycin and Cancer of Cervix
Article | Year |
---|---|
Combined chemotherapy and radiation therapy for cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Female; Fluorouracil; Humans; Hydroxyurea; Mitomycin; Nitroimidazoles; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2004 |
Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: a meta-analysis.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Middle Aged; Nitroimidazoles; Randomized Controlled Trials as Topic; Survival Analysis; Uterine Cervical Neoplasms | 2005 |
14 trial(s) available for azomycin and Cancer of Cervix
Article | Year |
---|---|
A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
Topics: COVID-19; Female; Humans; Hypoxia; Metformin; Nitroimidazoles; Pandemics; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2022 |
Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
Topics: Adaptation, Biological; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nitroimidazoles; Periodicity; Pilot Projects; Positron-Emission Tomography; Radiography; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Uterine Cervical Neoplasms | 2010 |
The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
Topics: Adult; Aged; Aged, 80 and over; Cell Hypoxia; Female; Humans; Middle Aged; Nitroimidazoles; Oxygen; Partial Pressure; Prognosis; Prospective Studies; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 2006 |
The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
Topics: Adult; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Spheroids, Cellular; Uterine Cervical Neoplasms | 2006 |
A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
Topics: Double-Blind Method; Drug Evaluation; Female; Hearing Loss; Humans; Kinetics; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Random Allocation; Thrombocytopenia; Uterine Cervical Neoplasms | 1982 |
[Clinical trials of hypoxic cell sensitizer misonidazole].
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Random Allocation; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1983 |
The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Topics: Adult; Aged; Brachytherapy; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prognosis; Radiation Injuries; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1984 |
Detection of a reactive metabolite of misonidazole in human urine.
Topics: Combined Modality Therapy; Female; Humans; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1984 |
[Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Oxygen; Stomach Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms | 1984 |
A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix.
Topics: Adolescent; Adult; Aged; Blood Transfusion; Brachytherapy; Carcinoma, Squamous Cell; Diarrhea; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Remission Induction; Survival Rate; Uterine Cervical Neoplasms; Vomiting | 1993 |
A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
Topics: Biomarkers; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Metallothionein; Neoplasm Staging; Nitroimidazoles; Proliferating Cell Nuclear Antigen; Protein Precursors; Uterine Cervical Neoplasms | 2000 |
Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
Topics: Antibodies; Biopsy; Diffusion; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hypoxia; Idoxuridine; Kinetics; Male; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents; Rectal Neoplasms; Regional Blood Flow; Specimen Handling; Uterine Cervical Neoplasms | 2001 |
Proceedings: The response of tumours to x rays and RO-07-0582.
Topics: Female; Humans; Methods; Neoplasms; Nitroimidazoles; Radiation Dosage; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1976 |
Use of ornidazole in fractionated radiotherapy: dose tolerance, serum and tumour tissue concentration.
Topics: Adult; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Drug Tolerance; Female; Humans; Kinetics; Laryngeal Neoplasms; Male; Nitroimidazoles; Ornidazole; Radiation-Sensitizing Agents; Random Allocation; Uterine Cervical Neoplasms | 1986 |
36 other study(ies) available for azomycin and Cancer of Cervix
Article | Year |
---|---|
MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer.
Topics: Algorithms; Animals; Cell Line, Tumor; Chemoradiotherapy; Contrast Media; Epithelial-Mesenchymal Transition; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; M Phase Cell Cycle Checkpoints; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Oxidative Phosphorylation; Oxygen Consumption; Prognosis; Treatment Outcome; Tumor Hypoxia; Uterine Cervical Neoplasms | 2020 |
DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
Topics: Actins; Angiogenesis Inhibitors; Animals; Bevacizumab; Capillary Permeability; Contrast Media; Female; Heterografts; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Nitroimidazoles; Oxygen Consumption; Pericytes; Tumor Hypoxia; Tumor Microenvironment; Uterine Cervical Neoplasms | 2019 |
DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
Topics: Animals; Cell Hypoxia; Cell Survival; Contrast Media; Female; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Influence of PEG-conjugated hemoglobin on tumor oxygenation and response to chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Substitutes; Cisplatin; Drug Synergism; Female; Hemoglobins; Hypoxia; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxygen Consumption; Polyethylene Glycols; Treatment Outcome; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.
Topics: Animals; Carcinoma, Squamous Cell; Female; Gingival Neoplasms; Humans; Hypoxia; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2010 |
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cinnamates; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Immunoenzyme Techniques; Lactates; Linear Models; Luminescent Measurements; Mice; Mice, Nude; Monocarboxylic Acid Transporters; Nitroimidazoles; Oxidation-Reduction; Symporters; Tumor Microenvironment; Uterine Cervical Neoplasms | 2011 |
pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Connective Tissue; Female; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2012 |
Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Imaging, Three-Dimensional; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
Topics: Animals; Body Weight; Cell Line, Tumor; Collagen; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Hypoxia; Image Processing, Computer-Assisted; Laminin; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Positron-Emission Tomography; Proteoglycans; Radiotherapy; Uterine Cervical Neoplasms | 2013 |
Orally administered pimonidazole to label hypoxic tumor cells.
Topics: Administration, Oral; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Flow Cytometry; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Nitroimidazoles; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Topics: Adult; Antigens, Neoplasm; Biomarkers; Biopsy; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; DNA-Binding Proteins; Energy Metabolism; Female; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Microelectrodes; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Proteins; Nitroimidazoles; Nuclear Proteins; Observer Variation; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Reproducibility of Results; Transcription Factors; Uterine Cervical Neoplasms | 2003 |
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
Topics: Adolescent; Adult; Analysis of Variance; Carcinoma; Cell Hypoxia; Computer Graphics; Female; Humans; Microelectrodes; Nitroimidazoles; Oxygen; Polarography; Radiation-Sensitizing Agents; Retrospective Studies; Statistics, Nonparametric; Uterine Cervical Neoplasms | 2003 |
Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
Topics: Biopsy; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Female; Humans; Hypoxia; Immunohistochemistry; In Situ Hybridization; Metallothionein; Nitroimidazoles; Oxygen; Prognosis; Protein Precursors; Radiation-Sensitizing Agents; RNA, Messenger; Transcription, Genetic; Uterine Cervical Neoplasms | 2003 |
Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, SCID; Nitroimidazoles; Oxygen; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2004 |
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Disease-Free Survival; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ion-Selective Electrodes; Middle Aged; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen; Prognosis; Radiation-Sensitizing Agents; Survival Rate; Transcription Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
Topics: Animals; Antigens, Neoplasm; Astrocytoma; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Image Processing, Computer-Assisted; Mice; Mice, SCID; Necrosis; Neoplasms; Nitroimidazoles; Transcription Factors; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2005 |
Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cervix Uteri; DNA, Neoplasm; Electrodes; Female; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Middle Aged; Nitroimidazoles; Oxygen; Phenotype; Predictive Value of Tests; Prognosis; S Phase; Time Factors; Uterine Cervical Neoplasms | 2006 |
[Experimental studies on radiosensitization of hypoxic cancer cells].
Topics: Animals; Carcinoma, Squamous Cell; Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Uterine Cervical Neoplasms | 1983 |
[Flow-microfluorometric studies on the effect of misonidazole as a radiosensitizer for human uterine cervical carcinoma transplanted to nude mice].
Topics: Animals; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Uterine Cervical Neoplasms | 1983 |
[Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
Topics: Animals; Cobalt Radioisotopes; Female; Genital Neoplasms, Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Ovarian Neoplasms; Radiotherapy, High-Energy; Uterine Cervical Neoplasms; Uterine Neoplasms | 1982 |
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
Topics: Breast Neoplasms; Female; Humans; Misonidazole; Necrosis; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Uterine Cervical Neoplasms | 1981 |
Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Topics: Adult; Antigens, Nuclear; Biomarkers; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Nitroimidazoles; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1997 |
Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
Topics: Biomarkers; Carcinoma, Squamous Cell; Cell Hypoxia; Endothelial Growth Factors; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphokines; Nitroimidazoles; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Topics: Biomarkers; Cell Division; Cell Hypoxia; Female; Humans; Immunohistochemistry; Nitroimidazoles; Proliferating Cell Nuclear Antigen; S Phase; Uterine Cervical Neoplasms | 1998 |
Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
Topics: Adenocarcinoma; Blood Vessels; Carcinoma, Squamous Cell; Cell Hypoxia; Diffusion; Esophageal Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Nitroimidazoles; Observer Variation; Radiation-Sensitizing Agents; Rectal Neoplasms; Reproducibility of Results; Uterine Cervical Neoplasms | 2000 |
Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Hypoxia; Comet Assay; Cricetinae; Cricetulus; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Immunoconjugates; Male; Mice; Mice, Inbred C3H; Mice, Inbred NOD; Mice, SCID; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2000 |
Semiquantitative immunohistochemical analysis for hypoxia in human tumors.
Topics: Calibration; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Nitroimidazoles; Observer Variation; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 2001 |
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cell Hypoxia; Female; Humans; Middle Aged; Nitroimidazoles; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 2001 |
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Topics: Animals; Antigens, Neoplasm; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Female; Glioma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2001 |
The range of oxygenation in SiHa tumor xenografts.
Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2002 |
Developments in radiotherapy other than heavy particle beams.
Topics: Animals; Brain Neoplasms; Energy Transfer; Fast Neutrons; Female; Glioblastoma; Hot Temperature; Humans; Mammary Neoplasms, Experimental; Metronidazole; Mice; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; X-Rays | 1977 |
[New aspects of the therapy for urogenital trichomoniasis].
Topics: Female; Humans; Nitroimidazoles; Trichomonas Vaginitis; Uterine Cervical Neoplasms | 1978 |
The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours.
Topics: Cell Survival; Female; Humans; In Vitro Techniques; Misonidazole; Nitroimidazoles; Oxygen; Uterine Cervical Neoplasms | 1978 |
Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer: evidence of diffusion from urine.
Topics: Carcinoma, Squamous Cell; Diffusion; Etanidazole; Female; Humans; Nitroimidazoles; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1989 |
The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors.
Topics: Breast Neoplasms; Female; Humans; Melanoma; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms | 1989 |
A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Topics: Adult; Aged; Animals; Carcinoma, Squamous Cell; Cricetinae; Cricetulus; Female; Humans; Male; Melanoma; Mice; Middle Aged; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1986 |